Giant cell arteritis. Part II. Treatment
Treatment options for giant cell arteritis (GCA) and its complications are considered. GCA is treatable with glucocorticoids (GC). The data available in the literature suggest that it is necessary to hospitalize GCA patients with acute vision loss or brain ischemia to administer intravenous megadose...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2012-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/447 |
| Summary: | Treatment options for giant cell arteritis (GCA) and its complications are considered. GCA is treatable with glucocorticoids (GC). The data available in the literature suggest that it is necessary to hospitalize GCA patients with acute vision loss or brain ischemia to administer intravenous megadose methylprednisolone and to control and prevent complications of GC therapy. It is expedient to use aspirin in these cases. The evidence for the use of methotrexate and other disease-modifying antirheumatic and genetically engineered drugs as GC-saving drugs is discussed. |
|---|---|
| ISSN: | 1996-7012 2310-158X |